TM
DMTK

Triatomic Management’s DermTech, Inc. Common Stock DMTK Stock Holding History

Triatomic Management’s Portfolio DMTK Stock Details DMTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-412,526
Closed -$290K – 26
2024
Q1 		$290K Buy
412,526
+10,000
+2% +$11.3K 0.54% 19
2023
Q4 		$704K Hold
402,526
– – 0.9% 21
2023
Q3 		$580K Buy
402,526
+1,200
+0.3% +$3K 0.4% 34
2023
Q2 		$1.04M Buy
401,326
+246,674
+160% +$738K 1.07% 19
2023
Q1 		$569K Buy
154,652
+27,444
+22% +$116K 0.38% 37
2022
Q4 		$225K Sell
127,208
-104,357
-45% -$278K 0.19% 41
2022
Q3 		$917K Buy
231,565
+66,372
+40% +$408K 0.53% 28
2022
Q2 		$915K Sell
165,193
-44,255
-21% -$362K 0.84% 24
2022
Q1 		$3.08M Buy
209,448
+93,531
+81% +$1.25M 2.5% 11
2021
Q4 		$1.83M Buy
+115,917
New +$2.78M 1.12% 22

Other funds holding DMTK

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
PA
PSI Advisors Tampa, Florida $418M AUM 15.55% 1-Year Est. Return
GWSA
Global Wealth Strategies & Associates Denver, Colorado $528M AUM 23.18% 1-Year Est. Return
T2I
Turim 21 Investimentos Rio De Janeiro, Brazil $399M AUM 20.13% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $208B AUM 16.12% 1-Year Est. Return

Triatomic Management's DMTK Position: Q2 2024 in Review

Triatomic Management sold out of DermTech, Inc. Common Stock (DMTK) in Q2 2024, closing a stake of 412,526 shares — an estimated $290K sold.

Triatomic Management first reported a position in DMTK in Q4 2021 and held it in 10 quarters. The position peaked at $3.08M in Q1 2022. 8 funds tracked by Wall St. Rank hold DMTK as of Q2 2024.

  • Triatomic Management reported no remaining DermTech, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Triatomic Management sold 412,526 DermTech, Inc. Common Stock shares in Q2 2024, an estimated $290K.
  • Triatomic Management first reported a position in DermTech, Inc. Common Stock in Q4 2021 and held it in 10 quarters.
  • Triatomic Management's DermTech, Inc. Common Stock position peaked at $3.08M in Q1 2022.
  • 8 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q2 2024.

Based on Triatomic Management's 13F filing for Q2 2024, filed 14 Aug 2024.